CLONIDINE 0.3 MG/DAY PATCH

What it is

CLONIDINE 0.3 MG/DAY PATCH is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “clonidine” and “clonidine transdermal system”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Clonidine Transdermal System USP, 0.3 mg/day”.

FDA gives its dosage form as “patch” and “patch, extended release” and its route as transdermal.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Actavis Pharma, Inc. and TruPharma, LLC.

FDA’s Established Pharmacologic Class for it is Central alpha-2 Adrenergic Agonist.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes); the FDA directory lists 5 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $12.29 for 1 patch (1 × $12.29116 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · NADAC explanation codes

The 4 labelers

When these prices took effect

• 2026-09-30 · 1 NDC · $12.29116 per EA filed
• 2026-09-23 · 7 NDCs · $12.29116 per EA filed

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with CLONIDINE 0.3 MG/DAY PATCH.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $12.29116 per EA filed.

Of the 22 other products in FDA’s Central alpha-2 Adrenergic Agonist class priced per EA, 1 has a higher middle NADAC price and 21 a lower one. The one in the middle is GUANFACINE HCL ER 2 MG TABLET, at $0.14767 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $18.68 for 1 patch, at an average of $18.68245 per EA in 2024 (2024-01-01 to 2024-12-31) for “Clonidine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 473,634 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

6 of the product’s 8 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 patch? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.